Clinical trial
Systemic and Topical Antivirals for Control of Cytomegalovirus Anterior Uveitis: Treatment
NCT03586284 is registered in ClinicalTrials.gov with University of California, San Francisco as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Systemic and Topical Antivirals for Control of Cytomegalovirus Anterior Uveitis: Treatment
- Lead sponsor
- University of California, San Francisco
- Phase
- Phase 2/3
- Overall status
- Terminated
- Start date
- March 15, 2020
- Completion date
- November 13, 2024
- Enrollment
- 51 (actual)
- Sites
- 4
Conditions
As the registry lists them; a condition with its own page is linked.
cytomegalovirus anterior uveitis